FDEMS Scoring System - For Objective Assessment of Motivation Level And Achievement of Glycemic Goals in Patients with Type 2 Diabetes Mellitus
FDEMS scoring system-for objective assessment of motivation level and achievement of glycemic goals
DOI:
https://doi.org/10.70284/njirm.v8i1.1178Keywords:
motivation level; type 2 diabetes mellitus, FDEMS score, glycemic control, SMBG, complianceAbstract
Aims and objective: To evaluate the objective assessment of motivation level in patients with type 2 diabetes mellitus (T2DM) by FDEMS scoring system and its correlation with achievement of glycemic goals. Methods: A retrospective, observational study analyzing follow up data of 46 patients with T2DM, using observations recorded at Morning Clinic, Jabalpur (MP, India) was performed from April 2014 to January 2016. The motivation level was objectively assessed with the help of a composite FDEMS score, comprising of following indices - (F) follow up, adherence to (D)dietary & (E)exercise advisory, along with (M)medication compliance and (S, SMBG) self monitoring of blood glucose levels, abbreviated as FDEMS score. The details were collected from the patients follow up charts. A score of 1 was given on satisfactory adherence to each index observed. The composite FDEMS score varied from a maximum of 5 to a minimum of 1. Glycemic control in terms of HbA1c level and change in weight, from baseline was calculated and subjected to statistical analysis. Results: Cohort of patients with higher FDEMS scores (≥3) had a greater proportion of those achieving HbA1c targets respectively as compared to those with lower FDEMS scores (≤2). This difference is statistically significant, in patients with duration of T2DM ≤ 10 yrs (P 0.024). Patients having higher FDEMS score ≥ 3 experienced a greater weight reduction, as compared to patients who had lower FDEMS score ≤2, irrespective of duration of T2DM (P 0.008; diabetes duration ≤ 10 years, P 0.0001; diabetes duration > 10 years). [Sachin K NJIRM 2017; 8(1): 92-96]
References
Knowler WC, Barrett-Connor E, Fowler SE. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346:393-403.
3. American Diabetes Association. Prevention or Delay of Type 2 Diabetes. Diabetes Care 2016; 39(Suppl. 1):S36-8.
4. Kaufman FR, Halvorson M, Carpenter S. Association between Diabetes Control and Visits to a Multidisciplinary Pediatric Diabetes Clinic. Pediatrics 1999; 103 (5): 1-6.
5. Khan NA, Venkatachalam VV, Al Akhali KM, Alavudeen SS, Dhanapal CK, Mohammad AAS. Overview of Glycemic Control, Knowledge, Awareness and Attitude among Type-2 Diabetes Male Patient's. J App Pharm 2015; 7 (1): 75-82.
6. Davis CL, Pollock NK, Waller JL. Exercise dose and diabetes risk in overweight and obese children: a randomized controlled trial. JAMA 2012; 308:1103-12.
7. Friedenreich CM, Orenstein MR. Physical activity and cancer prevention: etiologic evidence and biological mechanisms. J Nutr 2002; 132 (Suppl.):3456S-64S.
8. Bohn B, Herbst A, Pfeifer M, Krakow D, Zimny S, Kopp F et al. Impact of Physical Activity on Glycemic Control and Prevalence of Cardiovascular Risk Factors in Adults With Type 1 Diabetes: A Cross-sectional Multicenter Study of 18,028 Patients. Diabetes Care 2015; 38:1536-43.
9. Ahmad NS, Islahudin F, Paraidathathu T. Factors associated with good glycemic control among patients with type 2 diabetes mellitus. J Diabetes Invest 2014; 5: 563-9.
10. Pascal IGU, Ofoedu JN, Uchenna NP, Nkwa AA, Uchamma GUE. Blood Glucose Control and Medication Adherence Among Adult Type 2 Diabetic Nigerians Attending aPrimary Care Clinic in Under-resourced Environment of Eastern Nigeria. N Am J Med Sci 2012; 4(7): 310–5.
11. Sontakke S, Jadhav M, Pimpalkhute S, Jaiswal K, Bajait C. Evaluation of Adherence to Therapy in Patients of Type 2 Diabetes Mellitus. Journal of Young Pharmacists 2015; 7 (4-Supple):462-9.
12. Rodbard HW, Blonde L, Braithwaite SS. AACE Diabetes Mellitus Clinical Practice Guidelines Task Force. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract 2007;13(Suppl. 1):1–68
13. American Diabetes Association. Standards of medical care in diabetes–2010. Diabetes Care 2009; 32(Suppl. 1):S4-10.
14. Polonsky WH, Fisher L, Schikman CH, Hinnen DA, Parkin CG, Jelsovsky Z et al. Structured Self-Monitoring of Blood Glucose Significantly Reduces A1C Levels in Poorly Controlled, Noninsulin-Treated Type 2 Diabetes. Diabetes Care 2011; 34:262-7.
15. Garcıa-Perez LE, Alvarez M, Dilla T, Gil-Guillen V, Orozco-Beltran D. Adherence to Therapies in Patients with Type 2 Diabetes. Diabetes Ther 2013: 4:175-94.
16. Kavouras SA, Panagiotakos DB, Pitsavos C, Chrysohoou C, Anastasiou CA, Lentzas Y et al. Physical Activity, Obesity Status, and Glycemic Control: The ATTICA Study. Medicine & Science in Sports & Exercise 2007; 607-11.
17. American Diabetes Association. Obesity Management for the Treatment of Type 2 Diabetes. Diabetes Care 2016; 39(Suppl. 1):S47-51.
18. Pastors JG, Warshaw H, Daly A, Franz M, Kulkarni K. The evidence for the effectiveness of medical nutrition therapy in diabetes management. Diabetes Care 2002; 25:608-13.
